Zhejiang Kangmu Pharmaceutical

Zhejiang Kangmu Pharmaceutical is a Chinese veterinary pharmaceutical manufacturing company within the Kangmu Animal Health group. The company focuses on animal treatment, animal health care, and animal nutrition, with commercial products spanning veterinary active pharmaceutical ingredients, finished veterinary medicines, feed additives, and pet medications. Its disclosed core products include florfenicol, tilmicosin, tilmicosin phosphate, and thiamphenicol, and the broader group also references doxycycline, enrofloxacin, beta-carotene, canthaxanthin, tylosin, and astaxanthin-related product lines. Kangmu emphasizes integrated capabilities across chemical synthesis, biological fermentation, formulation, and manufacturing, and describes itself as a national high-tech enterprise with export activities. The business appears to be commercially oriented rather than a clinical-stage biotech, with operations centered in Shengzhou, Zhejiang, China.